CASE REPORT
Published on 03 Feb 2025
Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report
doi 10.3389/fonc.2025.1385794
- 153 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Advancements and Cutting-Edge Approaches to Counteract the Inefficacy of Immune Checkpoint Inhibitor Therapies in Lung Cancer
Advancements and Cutting-Edge Approaches to Counteract the Inefficacy of Immune Checkpoint Inhibitor Therapies in Lung Cancer
8,076
Total downloads
23k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review
doi 10.3389/fonc.2024.1334957
- 558 views
ORIGINAL RESEARCH
Published on 09 Aug 2024
Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm
doi 10.3389/fonc.2024.1403392
- 2,549 views
ORIGINAL RESEARCH
Published on 05 Jul 2024
Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study
doi 10.3389/fonc.2024.1398357
- 811 views
REVIEW
Published on 05 Jun 2024
Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1384121
- 2,174 views
- 3 citations
SYSTEMATIC REVIEW
Published on 16 May 2024
Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis
doi 10.3389/fonc.2024.1385761
- 1,327 views
SYSTEMATIC REVIEW
Published on 08 May 2024
Association between immune-related adverse events and prognosis in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1402017
- 806 views
CASE REPORT
Published on 23 Apr 2024
ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report
doi 10.3389/fonc.2024.1395654
- 1,004 views
ORIGINAL RESEARCH
Published on 18 Apr 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1332303
- 1,089 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Feb 2024
MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?
doi 10.3389/fimmu.2024.1344858
- 1,189 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Jan 2024
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study
doi 10.3389/fonc.2024.1303543
- 1,050 views
CASE REPORT
Published on 12 Jan 2024
Case report: Checkpoint inhibitor pneumonitis with positive anti-melanoma differentiation-associated gene 5 antibodies in a patient with lung cancer
doi 10.3389/fimmu.2023.1309531
- 1,049 views
- 1 citation
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 23kTopic views
- 14kArticle views
- 8,076Article downloads